These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 10494773)

  • 1. Elevated plasma fibrinogen and increased fibrin turnover among healthy women who both smoke and use low-dose oral contraceptives--a preliminary report.
    Scarabin PY; Vissac AM; Kirzin JM; Bourgeat P; Amiral J; Agher R; Guize L
    Thromb Haemost; 1999 Sep; 82(3):1112-6. PubMed ID: 10494773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte tissue factor expression is enhanced in women who smoke and use oral contraceptives.
    Hölschermann H; Terhalle HM; Zakel U; Maus U; Parviz B; Tillmanns H; Haberbosch W
    Thromb Haemost; 1999 Dec; 82(6):1614-20. PubMed ID: 10613644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease.
    Wannamethee SG; Lowe GD; Shaper AG; Rumley A; Lennon L; Whincup PH
    Eur Heart J; 2005 Sep; 26(17):1765-73. PubMed ID: 15817606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrin clot properties in women heterozygous for factor V Leiden mutation: effects of oral contraceptives.
    Krzek M; Ciesla-Dul M; Zabczyk M; Undas A
    Thromb Res; 2012 Oct; 130(4):e216-21. PubMed ID: 22940058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of oral contraceptives and mortality during 14 years' follow-up of Norwegian women.
    Graff-Iversen S; Hammar N; Thelle DS; Tonstad S
    Scand J Public Health; 2006; 34(1):11-6. PubMed ID: 16449039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 30 years of change: the current perspective on cardiovascular risks and oral contraceptives.
    Contracept Rep; 1995 May; 6(2):4-9, 14. PubMed ID: 12319497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic response to exercise in women using third-generation oral contraceptives.
    Weiss C; Walter B; Dorsch MF; Bärtsch P
    Blood Coagul Fibrinolysis; 2006 Oct; 17(7):563-8. PubMed ID: 16988552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptive use and smoking habits in young Israeli women: a cross-sectional study.
    Zimlichman E; Mandel D; Mimouni FB; Wartenfeld R; Huerta M; Grotto I; Kreiss Y
    Isr Med Assoc J; 2004 Sep; 6(9):546-9. PubMed ID: 15373313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial changes in plasma fibrinogen concentration and fibrinolytic activity in African women on oral contraceptive pills.
    Famodu AA
    Afr J Reprod Health; 1997 Sep; 1(2):90-5. PubMed ID: 10214418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemostasis and oral contraceptives.
    Farag A; Bottoms SF; Mammen EF; Hosni M; Ali A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):340-5. PubMed ID: 2465227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemostatic risk factors for cardiovascular diseases.
    Koenig W
    Eur Heart J; 1998 Apr; 19 Suppl C():C39-43. PubMed ID: 9597424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balance of coagulation activity with fibrinolysis during use of oral contraceptives in women with insulin-dependent diabetes mellitus.
    Petersen KR; Skouby SO; Jespersen J
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():105-11. PubMed ID: 8574252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemostatic and fibrinolytic factors in men with a small abdominal aortic aneurysm.
    Parry DJ; Al-Barjas HS; Chappell L; Rashid T; Ariëns RA; Scott DJ
    Br J Surg; 2009 Aug; 96(8):870-7. PubMed ID: 19591171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women.
    Peverill RE; Teede HJ; Malan E; Kotsopoulos D; Smolich JJ; McGrath BP
    Clin Sci (Lond); 2007 Nov; 113(9):383-91. PubMed ID: 17608627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined contraceptives and cardiovascular risk].
    Belaisch J; Hommais-loufrani B
    Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.